We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Treatment With Allergy Drug Builds Tolerance For Milk Among Allergic Children

March 21, 2011: 07:57 PM EST
U.S. scientists have found in a clinical study involving 11 milk-allergic children that treatment with the allergy drug omalizumab along with gradually increased exposure to milk built up a tolerance. Nine of the 11 children passed a double-blind food challenge and were eventually able to consume the equivalent of eight ounces of milk or more a day without an allergic reaction. According to the scientists, omalizumab (marketed by Genentech as Xolair) binds up IgE antibodies that drive allergic responses. Milk allergy is the most common form of allergy affecting the three million U.S. children who suffer from food allergies. The researchers said their next project will be a similar clinical trial among people with peanut allergy.
Renee Reijo Pera, "New treatment may desensitize kids with milk allergies, say researchers at Stanford and Children's Hospital Boston", Presentation, AAAAI annual meeting, March 21, 2011, © Stanford School of Medicine
Vitality & Better Living
North America
United States of America
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.